Ardelyx, Inc.

NASDAQ:ARDX

Biotechnology

Healthcare
$3.06 -1.03%

-$0.06 today

Market cap
$769.20M
Beta
0.58
P/E (TTM)
-24.5
EPS (TTM)
-$0.24
52W Low $3.49High $8.40

Volume 3.39M

Average 3.58M

Balance Sheet

Inspect the capital base behind the business.

Assets

$501.60M

FY 2025 · Annual

+15.1% YoY

Liabilities

$334.65M

FY 2025 · Annual

+27.5% YoY

Equity

$166.95M

FY 2025 · Annual

-3.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents72.43M96.14M21.47M64.93M68M
Short-term Investments44.26M27.77M162.83M185.17M196.69M
Net Receivables502K7.73M22.03M57.71M71.85M
Inventory03.28M12.45M21.17M17.74M
Other Current Assets15.11M8.41M11.1M13.57M
Total Current Assets133.65M153.6M246.11M356.45M382.32M
Property, Plant & Equipment (Net)15.11M10.52M6.6M3.88M6.98M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets1.15M25.95M44.87M75.43M112.31M
Total Non-current Assets16.26M36.46M51.47M79.3M119.29M
Total Assets149.91M190.07M297.58M435.75M501.6M
Account Payables4.28M10.86M11.14M16M19.24M
Short-term Debt32.26M26.71M001.48M
Tax Payables00000
Deferred Revenue04.21M7.18M10.69M1.21M
Other Current Liabilities1.24M10.09M15.04M21.48M66.69M
Total Current Liabilities52.82M65.6M50.39M77.83M88.61M
Long-term Debt0049.82M150.85M206.48M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)09.03M8.64M7.23M39.58M
Other Non-current Liabilities4.73M11.25M20.18M25.53M(3.64M)
Total Non-current Liabilities14.48M26.13M80.37M184.64M246.05M
Total Liabilities67.3M91.74M130.76M262.47M334.66M
Common Stock13K20K23K24K24K
Retained Earnings(712.93M)(780.14M)(846.2M)(885.34M)(946.94M)
Accumulated OCI(6K)(54K)224K57K198K
Other Stockholders Equity(0)0000
Minority Interest00000
Total Equity82.62M98.33M166.82M173.29M166.95M
Total Debt45.5M36.46M55.98M153.44M211.6M
Net Debt(26.92M)(59.68M)34.51M88.51M143.6M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$31.2M
Short-term Investments$206.9M
Receivables$82.8M
Inventory$22.7M
Other Current$38.2M
Total Current Assets$381.9M
PP&E (Net)$6.4M
Other Non-current$116.2M
Total Non-current Assets$122.6M
Total Assets$504.5M

Analysis

Selected assets total $504.5M for Latest. The largest visible component is Short-term Investments at $206.9M, about 41.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 3, 2026
8-KCurrent reportNov 3, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026
4Statement of changes in beneficial ownershipAug 25, 2026

How much cash does ARDX have?

Ardelyx, Inc. (ARDX) reported $68.00M in cash and equivalents in fiscal 2025.

How much debt does ARDX carry?

Ardelyx, Inc. (ARDX) reported $211.59M of total debt, with net debt of $143.60M.